There is a significant need for new treatments for patients with relapsed acute myeloid leukemia, a rare cancer of the
Continue reading »![](https://mypharmacynews.com/wp-content/uploads/sites/11/2019/01/cfarmafotomyeloidleuke-880x660.png)
mypharmacynews.com
There is a significant need for new treatments for patients with relapsed acute myeloid leukemia, a rare cancer of the
Continue reading »University of North Carolina Lineberger Comprehensive Cancer Center researchers have identified a potential way to target a subtype of acute
Continue reading »Quantitative three-dimensional analysis of bone wear patterns can provide insight into the manufacture and use of early human tools, according
Continue reading »A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one
Continue reading »St. Jude Children’s Research Hospital investigators have unraveled the origins and identified mutations associated with a perplexing form of acute
Continue reading »Acute myeloid leukemia is one of the most aggressive cancers. While other cancers have benefitted from new treatments, there has
Continue reading »While studying a large group of individuals with chronic lymphocytic leukemia (CLL), a Wilmot Cancer Institute scientific team made an
Continue reading »Clinical trials at University of Colorado Cancer Center and elsewhere now result in the drug ivosidenib earning approval from the
Continue reading »(HealthDay)—Tibsovo (ivosidenib) tablets have been approved by the U.S. Food and Drug Administration to treat relapsed or refractory acute myeloid
Continue reading »University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have
Continue reading »